| Literature DB >> 7037389 |
Abstract
Development of an immunotoxicology program within the pharmaceutical industry is described. With few guidelines in the area and a multitude of factors to consider, a basic screen for evaluating immune competence in species routinely used in toxicologic studies has been proposed. The future of immunotoxicology depends upon the ability of the selected immune function tests to be predictive of human risk.Entities:
Mesh：
Substances：
Year: 1982 PMID： 7037389 PMCID： PMC1568893 DOI： 10.1289/ehp.824353
Source DB: PubMed Journal: Environ Health Perspect ISSN： 0091-6765 Impact factor: 9.031